

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.41993105 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.21907256 |
| 3 | B cell receptor signaling pathway (GO:0050853) | 5.17713970 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 4.99557683 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.90494181 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.78440248 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.78440248 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.74473709 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54596192 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.54596192 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.52727490 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.41805747 |
| 13 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.37704194 |
| 14 | regulation of B cell differentiation (GO:0045577) | 4.35722807 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.16937669 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13969585 |
| 17 | leukocyte aggregation (GO:0070486) | 4.06914126 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00984166 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.00984166 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00984166 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00984166 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00984166 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 4.00984166 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.96411548 |
| 25 | positive thymic T cell selection (GO:0045059) | 3.89944967 |
| 26 | tolerance induction (GO:0002507) | 3.88684097 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.84727272 |
| 28 | activated T cell proliferation (GO:0050798) | 3.84333317 |
| 29 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.74972872 |
| 30 | regulation of germinal center formation (GO:0002634) | 3.70022859 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67939465 |
| 32 | negative T cell selection (GO:0043383) | 3.64333684 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61892022 |
| 34 | V(D)J recombination (GO:0033151) | 3.59737365 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54813582 |
| 36 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.53819996 |
| 37 | regulation of regulatory T cell differentiation (GO:0045589) | 3.53621723 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.50992381 |
| 39 | T cell selection (GO:0045058) | 3.47539041 |
| 40 | cellular response to zinc ion (GO:0071294) | 3.47445868 |
| 41 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.44280311 |
| 42 | T-helper cell differentiation (GO:0042093) | 3.44280311 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.43465135 |
| 44 | cellular extravasation (GO:0045123) | 3.41671835 |
| 45 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.39611985 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.37901565 |
| 47 | positive T cell selection (GO:0043368) | 3.33914730 |
| 48 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.31241341 |
| 49 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.30418855 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 3.30263859 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.30094463 |
| 52 | hepatocyte apoptotic process (GO:0097284) | 3.30081209 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.27461428 |
| 54 | negative regulation of bone resorption (GO:0045779) | 3.27014133 |
| 55 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26588928 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.26546543 |
| 57 | T cell homeostasis (GO:0043029) | 3.24466593 |
| 58 | alpha-beta T cell differentiation (GO:0046632) | 3.23965940 |
| 59 | * neutrophil activation (GO:0042119) | 3.22311079 |
| 60 | thymic T cell selection (GO:0045061) | 3.20935663 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.17279304 |
| 62 | detection of other organism (GO:0098543) | 3.16134127 |
| 63 | negative regulation of innate immune response (GO:0045824) | 3.14316481 |
| 64 | detection of bacterium (GO:0016045) | 3.13948166 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.13899641 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13375261 |
| 67 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.13144035 |
| 68 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.13144035 |
| 69 | lymphocyte homeostasis (GO:0002260) | 3.12984430 |
| 70 | mature B cell differentiation (GO:0002335) | 3.12342333 |
| 71 | RNA destabilization (GO:0050779) | 3.11237084 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.11213568 |
| 73 | myeloid dendritic cell activation (GO:0001773) | 3.09389271 |
| 74 | response to interleukin-15 (GO:0070672) | 3.07840945 |
| 75 | T cell differentiation (GO:0030217) | 3.06727494 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 3.06109155 |
| 77 | positive regulation of histone deacetylation (GO:0031065) | 3.05849872 |
| 78 | B cell homeostasis (GO:0001782) | 3.05347111 |
| 79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.04900320 |
| 80 | Peyers patch development (GO:0048541) | 3.04900320 |
| 81 | respiratory burst (GO:0045730) | 3.04641078 |
| 82 | germinal center formation (GO:0002467) | 3.04450869 |
| 83 | alpha-beta T cell activation (GO:0046631) | 3.03832710 |
| 84 | T cell differentiation involved in immune response (GO:0002292) | 3.02736271 |
| 85 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.02736271 |
| 86 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.02736271 |
| 87 | positive regulation of tolerance induction (GO:0002645) | 3.01706112 |
| 88 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.00747281 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.00343262 |
| 90 | interferon-gamma production (GO:0032609) | 3.00238352 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00190457 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00190457 |
| 93 | regulation of alpha-beta T cell activation (GO:0046634) | 3.00080158 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.98523699 |
| 95 | regulation of T cell mediated immunity (GO:0002709) | 2.98394869 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.97571673 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.97571673 |
| 98 | positive regulation of mRNA catabolic process (GO:0061014) | 2.95521593 |
| 99 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.95446948 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94672609 |
| 101 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.94018189 |
| 102 | defense response to protozoan (GO:0042832) | 2.93425034 |
| 103 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.93143082 |
| 104 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93121946 |
| 105 | angiogenesis involved in wound healing (GO:0060055) | 2.91149908 |
| 106 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90737827 |
| 107 | * granulocyte activation (GO:0036230) | 2.89379395 |
| 108 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.89129333 |
| 109 | negative regulation of interleukin-1 production (GO:0032692) | 2.88963800 |
| 110 | regulation of T cell tolerance induction (GO:0002664) | 2.88387916 |
| 111 | T cell migration (GO:0072678) | 2.85658873 |
| 112 | natural killer cell differentiation (GO:0001779) | 2.85348695 |
| 113 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.83998773 |
| 114 | mast cell activation (GO:0045576) | 2.82985791 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.79416621 |
| 116 | myeloid dendritic cell differentiation (GO:0043011) | 2.78329298 |
| 117 | response to peptidoglycan (GO:0032494) | 2.76712050 |
| 118 | B cell proliferation (GO:0042100) | 2.75609726 |
| 119 | cellular response to interleukin-15 (GO:0071350) | 2.75604292 |
| 120 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.75064438 |
| 121 | positive regulation of interleukin-2 production (GO:0032743) | 2.75009978 |
| 122 | leukocyte homeostasis (GO:0001776) | 2.74683983 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72950286 |
| 124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71763240 |
| 125 | positive regulation of mast cell degranulation (GO:0043306) | 2.71763240 |
| 126 | leukocyte cell-cell adhesion (GO:0007159) | 2.70386435 |
| 127 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.69089510 |
| 128 | negative regulation of B cell proliferation (GO:0030889) | 2.68919289 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.66892670 |
| 130 | regulation of B cell apoptotic process (GO:0002902) | 2.66290967 |
| 131 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66046007 |
| 132 | T cell receptor signaling pathway (GO:0050852) | 2.64337366 |
| 133 | pinocytosis (GO:0006907) | 2.64029029 |
| 134 | T cell costimulation (GO:0031295) | 2.63935846 |
| 135 | positive regulation of B cell activation (GO:0050871) | 2.62462098 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.61515857 |
| 137 | response to host immune response (GO:0052572) | 2.61515857 |
| 138 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61356835 |
| 139 | response to host (GO:0075136) | 2.61309496 |
| 140 | response to host defenses (GO:0052200) | 2.61309496 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61309496 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.59389652 |
| 143 | regulation of B cell proliferation (GO:0030888) | 2.58601827 |
| 144 | definitive hemopoiesis (GO:0060216) | 2.57272505 |
| 145 | lymphocyte costimulation (GO:0031294) | 2.57212120 |
| 146 | positive regulation of interferon-alpha production (GO:0032727) | 2.57156879 |
| 147 | response to laminar fluid shear stress (GO:0034616) | 2.54157557 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.50955253 |
| 149 | regulation of histone H3-K9 methylation (GO:0051570) | 2.50497184 |
| 150 | positive regulation of protein deacetylation (GO:0090312) | 2.50154584 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.49591260 |
| 152 | response to fungus (GO:0009620) | 2.49358050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74331020 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.76279904 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.10103321 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.07783320 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.97827035 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.91133222 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.40256214 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37498693 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.30851292 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24447857 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.19755903 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.16583344 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14204078 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.88415211 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74941768 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68731546 |
| 17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67954480 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66030758 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.65258104 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58522661 |
| 21 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52991135 |
| 22 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52333261 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.52070880 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45154403 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35648116 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34556347 |
| 27 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.34114082 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 2.28695550 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24534815 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19509133 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12983280 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12089220 |
| 33 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.10140356 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08815844 |
| 35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07226057 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03750928 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01073963 |
| 38 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93102945 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85589823 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79860125 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79241566 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78687471 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73393694 |
| 44 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.70595438 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67172878 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66619801 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65895618 |
| 48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64616574 |
| 49 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58042199 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54154255 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53604091 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53126885 |
| 53 | * MAF_26560356_Chip-Seq_TH2_Human | 1.51572426 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48249540 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44373004 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41995541 |
| 57 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.39575497 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39156938 |
| 59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38847419 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37030748 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36771945 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34924469 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32859881 |
| 64 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32081567 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28291973 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22854731 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22446853 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20167715 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16749249 |
| 70 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16665300 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16589758 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16460418 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16304518 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16157315 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10057913 |
| 76 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09741903 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08197368 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07829265 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07157649 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04612326 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04327274 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03895163 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03382483 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03033360 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02137738 |
| 86 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01739483 |
| 87 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.99751607 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98268657 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98022724 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97834268 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97560035 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96651719 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96259352 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95884913 |
| 95 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95286763 |
| 96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.94851326 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92601960 |
| 98 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90742998 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90515564 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89276738 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89064558 |
| 102 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88518937 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88002457 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85429073 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84630278 |
| 106 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84159033 |
| 107 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84040131 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82560087 |
| 109 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81206474 |
| 110 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81182418 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.80024257 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78269996 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.77889151 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77717576 |
| 115 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77516032 |
| 116 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77516032 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76367527 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75403789 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71465011 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69600470 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69315262 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68842318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.77853468 |
| 2 | MP0003303_peritoneal_inflammation | 3.75240455 |
| 3 | MP0001800_abnormal_humoral_immune | 3.39891500 |
| 4 | MP0000685_abnormal_immune_system | 3.19556424 |
| 5 | MP0005387_immune_system_phenotype | 3.14423569 |
| 6 | MP0001790_abnormal_immune_system | 3.14423569 |
| 7 | MP0002452_abnormal_antigen_presenting | 2.92640985 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.83428068 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.73624857 |
| 10 | MP0005671_abnormal_response_to | 2.71442071 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.66444630 |
| 12 | MP0002723_abnormal_immune_serum | 2.63819517 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.63743350 |
| 14 | * MP0001819_abnormal_immune_cell | 2.62583284 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.62086637 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.61473648 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.41356596 |
| 18 | * MP0003436_decreased_susceptibility_to | 2.40087302 |
| 19 | * MP0000716_abnormal_immune_system | 2.35121698 |
| 20 | MP0002419_abnormal_innate_immunity | 2.33825298 |
| 21 | MP0009278_abnormal_bone_marrow | 2.30147682 |
| 22 | MP0009785_altered_susceptibility_to | 2.28617981 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.26472251 |
| 24 | MP0005025_abnormal_response_to | 2.22166070 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.21715633 |
| 26 | MP0002722_abnormal_immune_system | 2.17772084 |
| 27 | MP0002405_respiratory_system_inflammati | 2.12132431 |
| 28 | * MP0000703_abnormal_thymus_morphology | 2.09020022 |
| 29 | MP0002006_tumorigenesis | 2.08436114 |
| 30 | * MP0002429_abnormal_blood_cell | 1.97946149 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.95209655 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.88788818 |
| 33 | MP0004510_myositis | 1.85775982 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.85477850 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.77190547 |
| 36 | MP0001873_stomach_inflammation | 1.75601804 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.68300312 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.68300312 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.64151608 |
| 40 | MP0001853_heart_inflammation | 1.60874730 |
| 41 | MP0004947_skin_inflammation | 1.60248854 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.59207707 |
| 43 | MP0008057_abnormal_DNA_replication | 1.57462659 |
| 44 | MP0006054_spinal_hemorrhage | 1.55118516 |
| 45 | MP0004381_abnormal_hair_follicle | 1.53022726 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.44278612 |
| 47 | MP0000490_abnormal_crypts_of | 1.43371328 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.43286795 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.37119746 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.36058490 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.33943412 |
| 52 | MP0003866_abnormal_defecation | 1.30541197 |
| 53 | MP0002933_joint_inflammation | 1.30338277 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.28447813 |
| 55 | MP0003448_altered_tumor_morphology | 1.23399343 |
| 56 | MP0003077_abnormal_cell_cycle | 1.21570024 |
| 57 | MP0000858_altered_metastatic_potential | 1.21375337 |
| 58 | * MP0000465_gastrointestinal_hemorrhage | 1.21191473 |
| 59 | MP0002009_preneoplasia | 1.21164917 |
| 60 | MP0010307_abnormal_tumor_latency | 1.20921403 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.20440968 |
| 62 | MP0005310_abnormal_salivary_gland | 1.16924587 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.15834495 |
| 64 | MP0006082_CNS_inflammation | 1.09087378 |
| 65 | MP0003724_increased_susceptibility_to | 1.07508605 |
| 66 | * MP0001533_abnormal_skeleton_physiology | 1.06644693 |
| 67 | MP0008007_abnormal_cellular_replicative | 1.05571295 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.00424166 |
| 69 | MP0008469_abnormal_protein_level | 0.98302740 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.97220385 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.94333179 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 0.94085578 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.92355751 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.92303569 |
| 75 | MP0001851_eye_inflammation | 0.90994075 |
| 76 | MP0003111_abnormal_nucleus_morphology | 0.90985678 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.90298797 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.88077659 |
| 79 | MP0002132_abnormal_respiratory_system | 0.86433403 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.85936382 |
| 81 | MP0003828_pulmonary_edema | 0.85800834 |
| 82 | MP0008995_early_reproductive_senescence | 0.85107900 |
| 83 | MP0004130_abnormal_muscle_cell | 0.84216799 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.84011119 |
| 85 | MP0009763_increased_sensitivity_to | 0.82959826 |
| 86 | MP0008260_abnormal_autophagy | 0.82149872 |
| 87 | MP0000343_altered_response_to | 0.81393987 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.80900140 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.79943375 |
| 90 | * MP0005390_skeleton_phenotype | 0.79896345 |
| 91 | MP0000350_abnormal_cell_proliferation | 0.78286183 |
| 92 | MP0001663_abnormal_digestive_system | 0.77515218 |
| 93 | MP0003693_abnormal_embryo_hatching | 0.76721596 |
| 94 | MP0004883_abnormal_blood_vessel | 0.76291248 |
| 95 | MP0003091_abnormal_cell_migration | 0.73228510 |
| 96 | MP0000604_amyloidosis | 0.70432715 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.69679527 |
| 98 | MP0000313_abnormal_cell_death | 0.68837926 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.68025025 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.67951038 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.66324477 |
| 102 | MP0001915_intracranial_hemorrhage | 0.65159717 |
| 103 | * MP0000249_abnormal_blood_vessel | 0.64432612 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.63556231 |
| 105 | MP0008058_abnormal_DNA_repair | 0.63316548 |
| 106 | MP0002928_abnormal_bile_duct | 0.61546342 |
| 107 | MP0005621_abnormal_cell_physiology | 0.61226499 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.58123826 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.56758676 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.55973601 |
| 111 | * MP0002136_abnormal_kidney_physiology | 0.54057243 |
| 112 | MP0003795_abnormal_bone_structure | 0.53611077 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.52797847 |
| 114 | MP0009764_decreased_sensitivity_to | 0.52651871 |
| 115 | MP0005023_abnormal_wound_healing | 0.52305393 |
| 116 | MP0003252_abnormal_bile_duct | 0.50329480 |
| 117 | MP0004484_altered_response_of | 0.50026187 |
| 118 | MP0005166_decreased_susceptibility_to | 0.50022947 |
| 119 | MP0005164_abnormal_response_to | 0.48565895 |
| 120 | MP0008877_abnormal_DNA_methylation | 0.47088989 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.44662148 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.44565312 |
| 123 | MP0000609_abnormal_liver_physiology | 0.40457454 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.38549767 |
| 125 | MP0009115_abnormal_fat_cell | 0.38163995 |
| 126 | MP0002653_abnormal_ependyma_morphology | 0.37485666 |
| 127 | MP0002083_premature_death | 0.37345140 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.37272340 |
| 129 | MP0008874_decreased_physiological_sensi | 0.37143698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cellulitis (HP:0100658) | 4.98531416 |
| 2 | Agammaglobulinemia (HP:0004432) | 4.96053529 |
| 3 | Recurrent viral infections (HP:0004429) | 4.82331951 |
| 4 | B lymphocytopenia (HP:0010976) | 4.73032835 |
| 5 | Abnormality of B cell number (HP:0010975) | 4.73032835 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.71219475 |
| 7 | Thyroiditis (HP:0100646) | 4.70424531 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.35734254 |
| 9 | Meningitis (HP:0001287) | 4.27321101 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.25714348 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.21400484 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.17456475 |
| 13 | T lymphocytopenia (HP:0005403) | 3.99563656 |
| 14 | Stomach cancer (HP:0012126) | 3.95085635 |
| 15 | IgM deficiency (HP:0002850) | 3.83559107 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.80838712 |
| 17 | * Papilloma (HP:0012740) | 3.80041242 |
| 18 | * Verrucae (HP:0200043) | 3.80041242 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.75827607 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.51499677 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.50023598 |
| 22 | Chronic otitis media (HP:0000389) | 3.44822413 |
| 23 | Colitis (HP:0002583) | 3.44421254 |
| 24 | Osteomyelitis (HP:0002754) | 3.43044515 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.42847543 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.42260156 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.37398786 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.35866029 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.33434182 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.33124447 |
| 31 | Obstructive lung disease (HP:0006536) | 3.33124447 |
| 32 | Eosinophilia (HP:0001880) | 3.29815120 |
| 33 | Prostate neoplasm (HP:0100787) | 3.24831929 |
| 34 | Combined immunodeficiency (HP:0005387) | 3.24484069 |
| 35 | Myositis (HP:0100614) | 3.14780936 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.05940494 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.03564290 |
| 38 | Abnormality of the fingertips (HP:0001211) | 3.03236521 |
| 39 | Abnormality of T cells (HP:0002843) | 3.02290916 |
| 40 | Recurrent skin infections (HP:0001581) | 3.00063324 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.96718809 |
| 42 | Sepsis (HP:0100806) | 2.96225413 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94611238 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94611238 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88301597 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.87475762 |
| 47 | Increased IgM level (HP:0003496) | 2.84666129 |
| 48 | Granulocytopenia (HP:0001913) | 2.82086641 |
| 49 | Chronic sinusitis (HP:0011109) | 2.75361188 |
| 50 | Leukocytosis (HP:0001974) | 2.73369363 |
| 51 | Vasculitis (HP:0002633) | 2.73356572 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.71514697 |
| 53 | Lymphopenia (HP:0001888) | 2.68238654 |
| 54 | Hypoplasia of the thymus (HP:0000778) | 2.63607232 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.63184152 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62992185 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60270933 |
| 58 | Small epiphyses (HP:0010585) | 2.47385518 |
| 59 | Increased density of long bones (HP:0006392) | 2.47009132 |
| 60 | Recurrent pneumonia (HP:0006532) | 2.46501705 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.46284338 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.43749370 |
| 63 | Chronic diarrhea (HP:0002028) | 2.41929603 |
| 64 | Thrombocytosis (HP:0001894) | 2.41834653 |
| 65 | Gangrene (HP:0100758) | 2.40833704 |
| 66 | Abnormality of the intervertebral disk (HP:0005108) | 2.40821594 |
| 67 | Periodontitis (HP:0000704) | 2.37474118 |
| 68 | Pulmonary embolism (HP:0002204) | 2.35949124 |
| 69 | Optic neuritis (HP:0100653) | 2.34491200 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.34491200 |
| 71 | Orchitis (HP:0100796) | 2.34082231 |
| 72 | Urticaria (HP:0001025) | 2.28348160 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.28238023 |
| 74 | Alveolar cell carcinoma (HP:0006519) | 2.26854716 |
| 75 | Chest pain (HP:0100749) | 2.25050691 |
| 76 | Abnormality of male internal genitalia (HP:0000022) | 2.24118872 |
| 77 | Hematochezia (HP:0002573) | 2.23695422 |
| 78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23656594 |
| 79 | Joint swelling (HP:0001386) | 2.23430066 |
| 80 | Encephalitis (HP:0002383) | 2.22339935 |
| 81 | Arterial thrombosis (HP:0004420) | 2.22092212 |
| 82 | Increased IgE level (HP:0003212) | 2.20781675 |
| 83 | Pulmonary fibrosis (HP:0002206) | 2.20747892 |
| 84 | Pustule (HP:0200039) | 2.20732292 |
| 85 | Gingivitis (HP:0000230) | 2.20066409 |
| 86 | Nasal polyposis (HP:0100582) | 2.20014278 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.19637916 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 2.18645704 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.16511541 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.16303152 |
| 91 | Lymphoma (HP:0002665) | 2.16074007 |
| 92 | Skin ulcer (HP:0200042) | 2.13638810 |
| 93 | Stomatitis (HP:0010280) | 2.11032613 |
| 94 | Volvulus (HP:0002580) | 2.10502078 |
| 95 | * IgG deficiency (HP:0004315) | 2.09389808 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 2.09024449 |
| 97 | Emphysema (HP:0002097) | 2.08272942 |
| 98 | Episodic fever (HP:0001954) | 2.08100844 |
| 99 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08037681 |
| 100 | Vertebral arch anomaly (HP:0008438) | 2.07097528 |
| 101 | Anorexia (HP:0002039) | 2.07036072 |
| 102 | Glomerulopathy (HP:0100820) | 2.05500710 |
| 103 | Keratitis (HP:0000491) | 2.04966588 |
| 104 | Bronchitis (HP:0012387) | 2.04023161 |
| 105 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.00436937 |
| 106 | Abnormal platelet volume (HP:0011876) | 1.98814859 |
| 107 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.97600317 |
| 108 | Epistaxis (HP:0000421) | 1.97354428 |
| 109 | Viral hepatitis (HP:0006562) | 1.97150082 |
| 110 | Skin rash (HP:0000988) | 1.96643754 |
| 111 | Premature loss of primary teeth (HP:0006323) | 1.96544798 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 1.95890065 |
| 113 | Cutis marmorata (HP:0000965) | 1.94899925 |
| 114 | Petechiae (HP:0000967) | 1.92743122 |
| 115 | Supernumerary ribs (HP:0005815) | 1.91234914 |
| 116 | Basal cell carcinoma (HP:0002671) | 1.88719084 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.88708532 |
| 118 | Restrictive lung disease (HP:0002091) | 1.88328583 |
| 119 | Recurrent otitis media (HP:0000403) | 1.88188215 |
| 120 | Mitral stenosis (HP:0001718) | 1.85528405 |
| 121 | Hemoptysis (HP:0002105) | 1.83945612 |
| 122 | Hypochromic anemia (HP:0001931) | 1.83758410 |
| 123 | Persistence of primary teeth (HP:0006335) | 1.83263967 |
| 124 | Abnormality of the thymus (HP:0000777) | 1.80830693 |
| 125 | Long eyelashes (HP:0000527) | 1.79908314 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.79573060 |
| 127 | Papilledema (HP:0001085) | 1.78133916 |
| 128 | Bicuspid aortic valve (HP:0001647) | 1.77981157 |
| 129 | IgA deficiency (HP:0002720) | 1.77512375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.58084884 |
| 2 | MAP4K1 | 4.31878790 |
| 3 | EEF2K | 2.59719005 |
| 4 | STK10 | 2.45210073 |
| 5 | MAP2K2 | 2.43606704 |
| 6 | BTK | 2.30055690 |
| 7 | IRAK4 | 2.13873200 |
| 8 | SYK | 2.03441780 |
| 9 | MAP3K14 | 2.00894207 |
| 10 | BLK | 1.98656729 |
| 11 | ITK | 1.96130712 |
| 12 | CDK12 | 1.92408735 |
| 13 | ERN1 | 1.87333673 |
| 14 | LRRK2 | 1.83185877 |
| 15 | TYK2 | 1.81681885 |
| 16 | CSF1R | 1.73890041 |
| 17 | TEC | 1.69555814 |
| 18 | CLK1 | 1.66405109 |
| 19 | TRIB3 | 1.64474120 |
| 20 | BMPR2 | 1.56023079 |
| 21 | KIT | 1.53796758 |
| 22 | ZAP70 | 1.52554968 |
| 23 | TGFBR2 | 1.52118669 |
| 24 | RIPK4 | 1.50255969 |
| 25 | FGFR3 | 1.49530095 |
| 26 | HCK | 1.47913848 |
| 27 | CSK | 1.46204409 |
| 28 | EPHB1 | 1.45485874 |
| 29 | PRPF4B | 1.43585001 |
| 30 | PKN2 | 1.42947060 |
| 31 | STK4 | 1.41835136 |
| 32 | TBK1 | 1.41328859 |
| 33 | TXK | 1.40030023 |
| 34 | EIF2AK3 | 1.39283679 |
| 35 | JAK1 | 1.34922332 |
| 36 | JAK3 | 1.32401616 |
| 37 | FES | 1.31260166 |
| 38 | TLK1 | 1.29300116 |
| 39 | * GRK6 | 1.28700024 |
| 40 | SIK2 | 1.25977218 |
| 41 | IKBKB | 1.24728802 |
| 42 | IRAK1 | 1.17238686 |
| 43 | TAOK3 | 1.17026065 |
| 44 | TESK2 | 1.16243863 |
| 45 | IKBKE | 1.14868288 |
| 46 | NLK | 1.14735211 |
| 47 | LCK | 1.12167185 |
| 48 | CDK4 | 1.12101842 |
| 49 | * PIM1 | 1.11012121 |
| 50 | LYN | 1.09565773 |
| 51 | NEK2 | 1.07106125 |
| 52 | CAMKK2 | 1.06142323 |
| 53 | CHUK | 1.06012271 |
| 54 | FGFR4 | 1.00464761 |
| 55 | MAPK15 | 0.97547015 |
| 56 | MST4 | 0.97530658 |
| 57 | MAP2K3 | 0.96708043 |
| 58 | CDK6 | 0.95433547 |
| 59 | CDK9 | 0.95405831 |
| 60 | IRAK3 | 0.95342844 |
| 61 | HIPK2 | 0.94211516 |
| 62 | KDR | 0.92736794 |
| 63 | CAMKK1 | 0.90579825 |
| 64 | PTK6 | 0.89225882 |
| 65 | TRPM7 | 0.83979229 |
| 66 | RPS6KA4 | 0.81392081 |
| 67 | MARK3 | 0.80450691 |
| 68 | DYRK1B | 0.79514988 |
| 69 | SIK3 | 0.79204283 |
| 70 | MAP3K13 | 0.73069560 |
| 71 | MAP3K8 | 0.72172959 |
| 72 | MAPK4 | 0.71974414 |
| 73 | RPS6KB2 | 0.71403218 |
| 74 | BRD4 | 0.70331357 |
| 75 | MAPK12 | 0.68835100 |
| 76 | CDC7 | 0.67907358 |
| 77 | JAK2 | 0.67360932 |
| 78 | ALK | 0.65219814 |
| 79 | MAP3K11 | 0.63285193 |
| 80 | MATK | 0.63135274 |
| 81 | PRKCQ | 0.62675081 |
| 82 | TNK2 | 0.62016341 |
| 83 | FGFR2 | 0.56980301 |
| 84 | TSSK6 | 0.55533322 |
| 85 | MAPK11 | 0.54533352 |
| 86 | PDK1 | 0.54144724 |
| 87 | IRAK2 | 0.53157835 |
| 88 | MARK2 | 0.52804838 |
| 89 | SGK3 | 0.52296739 |
| 90 | PIK3CG | 0.51516473 |
| 91 | MELK | 0.51179661 |
| 92 | DYRK3 | 0.50688787 |
| 93 | YES1 | 0.49876574 |
| 94 | RPS6KA6 | 0.49197039 |
| 95 | PRKD2 | 0.47404334 |
| 96 | RPS6KA5 | 0.46993366 |
| 97 | TTN | 0.45653126 |
| 98 | RPS6KL1 | 0.43759492 |
| 99 | RPS6KC1 | 0.43759492 |
| 100 | MAPK7 | 0.43392379 |
| 101 | GRK7 | 0.43021840 |
| 102 | MAP3K1 | 0.42999923 |
| 103 | FLT3 | 0.42729778 |
| 104 | MAPKAPK2 | 0.41821559 |
| 105 | MAP3K7 | 0.41725530 |
| 106 | EPHA3 | 0.41578162 |
| 107 | ADRBK2 | 0.40446658 |
| 108 | STK24 | 0.40252613 |
| 109 | PASK | 0.39609112 |
| 110 | MAPK3 | 0.39447594 |
| 111 | ABL1 | 0.39363510 |
| 112 | PAK4 | 0.39105065 |
| 113 | ATR | 0.38787985 |
| 114 | PDGFRB | 0.38768761 |
| 115 | FGR | 0.36856453 |
| 116 | SIK1 | 0.33551864 |
| 117 | KSR2 | 0.33107266 |
| 118 | RPS6KA1 | 0.33096621 |
| 119 | PRKD1 | 0.32273327 |
| 120 | EGFR | 0.32145253 |
| 121 | FYN | 0.30151263 |
| 122 | RPS6KA2 | 0.29450184 |
| 123 | INSR | 0.29315556 |
| 124 | IGF1R | 0.28417002 |
| 125 | TAOK1 | 0.27856282 |
| 126 | CAMK4 | 0.27699617 |
| 127 | NUAK1 | 0.26396739 |
| 128 | MOS | 0.24679126 |
| 129 | INSRR | 0.24587880 |
| 130 | CDC42BPA | 0.24188151 |
| 131 | CDK8 | 0.24162022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.74413187 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.37235033 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.88296374 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46568253 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46051987 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37714334 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19121771 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04918896 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.01887784 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.98101709 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94961375 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.93640537 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.86311434 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79977077 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.72232048 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71517496 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65236130 |
| 18 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62834493 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62593652 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.56323813 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53101982 |
| 22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.49396469 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46354804 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43093190 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.40522940 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40008626 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.39475454 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37464265 |
| 29 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.37358593 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.37080992 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.36703857 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36104541 |
| 33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34024938 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32496222 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31991204 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.31672332 |
| 37 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30207974 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.28101403 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26088373 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21580056 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.19722453 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18372839 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18243100 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13660995 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.11172143 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.10220054 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.10157270 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07856215 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06241885 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05212121 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04586016 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04373132 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02092554 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01174755 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.00071047 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99696673 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95278042 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93584846 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93017178 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93013796 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.92030914 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.86263661 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85618409 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.83155334 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.83021015 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.82923854 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82304788 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.81155256 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78343164 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76967600 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75384216 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.74882653 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73519897 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70702123 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.70278845 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69419736 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69161630 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.66639932 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65810961 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65647362 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.64097632 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.62973681 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62226243 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60747996 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.60336764 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.60009593 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59802231 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.58698738 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58490217 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58250639 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56856018 |
| 92 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56655853 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55954005 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54808865 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54673760 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54216463 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53543916 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53476528 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.52820018 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50369077 |
| 101 | * Endocytosis_Homo sapiens_hsa04144 | 0.49410060 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49184303 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48329306 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47760739 |
| 105 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.47223065 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46447661 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.43241154 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43150960 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.39141982 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38701589 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37803878 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36462053 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35916209 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.35562706 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32599675 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30048014 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29770854 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27801746 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27492873 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26881801 |
| 121 | Morphine addiction_Homo sapiens_hsa05032 | 0.26681773 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25733907 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20820472 |

